Early phase cancer immunotherapy /

Early phase cancer immunotherapy /

Saved in:

Bibliographic Details
Imprint:	Cham : Springer, ©2018.
Description:	1 online resource (336 pages)
Language:	English
Series:	Current Cancer Research Current cancer research.
Subject:	Cancer -- Immunotherapy. Neoplasms -- therapy. Immunotherapy -- methods. Clinical Trials, Phase I as Topic. Clinical Trials, Phase II as Topic. Cancer -- Immunotherapy.
Format:	E-Resource Book
URL for this record:	http://pi.lib.uchicago.edu/1001/cat/bib/11542267

Hidden Bibliographic Details
Other authors / contributors:	Patel, Sandip Pravin. Kurzrock, Razelle.
ISBN:	9783319637570 3319637576 9783319637563 3319637568
Digital file characteristics:	text file PDF
Notes:	""3.3.1.3 PD-L1 Expression inÂ Melanoma"" Includes bibliographical references. Print version record.
Summary:	This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
Other form:	Print version: Patel, Sandip Pravin. Early Phase Cancer Immunotherapy. Cham : Springer International Publishing, ©2017 9783319637563
Standard no.:	10.1007/978-3-319-63757-0

Description
Summary:	This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
Item Description:	""3.3.1.3 PD-L1 Expression inÂ Melanoma""
Physical Description:	1 online resource (336 pages)
Bibliography:	Includes bibliographical references.
ISBN:	9783319637570 3319637576 9783319637563 3319637568